Animal models for screening anxiolytic-like drugs: a perspective.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 4610614)

Published in Dialogues Clin Neurosci on September 01, 2015

Authors

Michel Bourin1

Author Affiliations

1: University of Nantes, France.

Articles cited by this

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods (1985) 9.05

The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl) (1987) 5.35

The mouse light/dark box test. Eur J Pharmacol (2003) 3.47

Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav Brain Res (2001) 2.98

The neurobiology and control of anxious states. Prog Neurobiol (2003) 2.48

Ethologically-based animal models of anxiety disorders. Pharmacol Ther (1990) 1.90

Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol Biochem Behav (1995) 1.74

Animal models of anxiety in mice. Fundam Clin Pharmacol (2007) 1.62

Modeling anxiety using adult zebrafish: a conceptual review. Neuropharmacology (2011) 1.28

The age of anxiety: role of animal models of anxiolytic action in drug discovery. Br J Pharmacol (2011) 1.25

Summary of a National Institute of Mental Health workshop: developing animal models of anxiety disorders. Psychopharmacology (Berl) (2001) 1.08

5-Hydroxytryptamine pathways in anxiety and its treatment. Pharmacol Ther (1995) 0.99

Influence of age on behavioural response in the light/dark paradigm. Physiol Behav (1999) 0.98

Animal models of anxiety: are they suitable for predicting drug action in humans? Pol J Pharmacol (1998) 0.95

Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice. Psychopharmacology (Berl) (1993) 0.94

Prior test experience compromises the anxiolytic efficacy of chlordiazepoxide in the mouse light/dark exploration test. Behav Brain Res (2001) 0.93

Animal models of anxiety disorders in rats and mice: some conceptual issues. Dialogues Clin Neurosci (2011) 0.92

A new approach to the light/dark test procedure in mice. Pharmacol Biochem Behav (1998) 0.89

Anxiolytic- but not antidepressant-like activity of Lu AF21934, a novel, selective positive allosteric modulator of the mGlu₄ receptor. Neuropharmacology (2012) 0.88

Brain structures implicated in the four-plate test in naïve and experienced Swiss mice using injection of diazepam and the 5-HT2A agonist DOI. Behav Brain Res (2009) 0.88

The gerbil elevated plus-maze I: behavioral characterization and pharmacological validation. Neuropsychopharmacology (2002) 0.86

Anxiolytic-like activity of agomelatine and melatonin in three animal models of anxiety. Behav Pharmacol (2006) 0.86

Odor-induced variation in anxiety-like behavior in mice is associated with discrete and differential effects on mesocorticolimbic cholecystokinin mRNA expression. Neuropsychopharmacology (2002) 0.85

Rodent models of anxiety-like behaviors: are they predictive for compounds acting via non-benzodiazepine mechanisms? Curr Opin Investig Drugs (2001) 0.82

Anxiolytic-like effect of 5-HT(2) ligands and benzodiazepines co-administration: comparison of two animal models of anxiety (the four-plate test and the elevated plus maze). Behav Brain Res (2006) 0.82

Anxiolytic-like effects of antidepressants after acute administration in a four-plate test in mice. Pharmacol Biochem Behav (2000) 0.81

Influence of prior experience on mice behavior using the four-plate test. Pharmacol Biochem Behav (1997) 0.81

Formyl peptide receptor as a novel therapeutic target for anxiety-related disorders. PLoS One (2014) 0.81

Implication of 5-HT2A subtype receptors in DOI activity in the four-plates test-retest paradigm in mice. Behav Brain Res (2005) 0.80

Effects of NMDA receptor blockade during the early development period on the retest performance of adult Wistar rats in the elevated plus maze. Neurochem Res (2013) 0.78

alpha2-Adrenergic agonists antagonise the anxiolytic-like effect of antidepressants in the four-plate test in mice. Behav Brain Res (2005) 0.78

Impairment in the aversive memory of mice in the inhibitory avoidance task but not in the elevated plus maze through intra-amygdala injections of histamine. Pharmacol Biochem Behav (2015) 0.77

Implication of 5-HT2 receptor subtypes in the mechanism of action of the GABAergic compound etifoxine in the four-plate test in Swiss mice. Behav Brain Res (2009) 0.77